v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (3,177) $ (1,429) $ (3,528) $ (3,057)
Adjustments to reconcile net loss to net cash used in operating activities:        
Gain from settlement of account payable     0 (363)
Share-based compensation expense 58 114 441 625
Changes in operating assets and liabilities:        
Accounts receivable 1,000 (25) (444) (556)
Prepaid expenses 129 165 37 21
Other current assets 0 (5) 5 (5)
Accounts payable (51) 93 118 (445)
Accrued research and development costs (50) (2) 146 (38)
Accrued expenses and other current liabilities 915 121 (89) (515)
Net cash used in operating activities (1,176) (968) (3,314) (4,333)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchases of property and equipment (66) 0    
Net cash used in investing activities (66) 0    
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from ATM 825 0 2,077 0
Proceeds from private placement 0 1,375 1,375 0
Issuance costs paid for private placement     (130) 0
Net cash provided by financing activities 825 1,375 3,322 0
Effect of exchange rate changes on cash and cash equivalents     0 (6)
Net increase (decrease) in cash and cash equivalents (417) 407 8 (4,339)
Cash and cash equivalents, beginning of period 3,240 3,232 3,232 7,571
Cash and cash equivalents, end of period $ 2,823 $ 3,639 $ 3,240 $ 3,232